About
Magda Kordon, PhD is the CEO and co-founder of intoDNA, the company pioneering DNA quality diagnostics with the STRIDE™ platform technology. Magda is an inventor on a patent describing this highly sensitive technique for the detection of free ends of DNA in situ. STRIDE™ works like an "X-ray" of DNA break detection translating to faster time-to-market for targeted therapeutics within the fields of DNA Damage Response (DDR), Radiotherapeutics and Immuno-Oncology.
Magda earned her PhD in Cell Biophysics from Jagiellonian University and was a visiting PhD student at UC Davis, Cold Spring Harbor Laboratory and UMass Medical School. With more than a decade of research experience and a proven track record of innovation, Magda leads intoDNA in harnessing the power of STRIDE™ to revolutionize and personalize targeted therapies in oncology.